Skip to main content
. 2023 Feb 12;15(4):1178. doi: 10.3390/cancers15041178
ALCL Anaplastic large cell lymphoma
AUC Area under the curve
BL Burkitt lymphoma
B-LBL B-cell lymphoblastic lymphoma
cHL Classical Hodgkin lymphoma
CI Confidence interval
CRP C-reactive protein
CV Cross validation
DLBCL Diffuse large B-cell lymphoma
ELISA Enzyme-linked immunosorbent assay
ESR Erythrocyte sedimentation rate
LD Lactate dehydrogenase
NHL Non-Hodgkin lymphoma
NLPHL Nodular lymphocyte-predominant Hodgkin lymphoma
OR Odds ratio
PMBCL Primary mediastinal large B-cell lymphoma
PTGC Progressive transformation of germinal centers
PTLD Post-transplant lymphoproliferative disorders
ROC Receiver operating characteristic
TARC Thymus and activation regulated chemokine
T-LBL T-cell lymphoblastic lymphoma